Michael Harrop
Active member
https://www.sciencedirect.com/science/article/pii/S2590097820300252
You can search the page for "herpes". It's in Section 5, Short-term and long-term safety of FMT in IBD.
It apparently occurred in multiple studies. It's listed under "placebo".
NSAE = Non-serious adverse events.
Highlights
- Fecal microbiota transplant is a new treatment for inflammatory bowel disease.
- Fecal microbiota transplant methods and related results vary among different centers.
- The progress of methods and strategy is moving fecal microbiota transplant forward.
- Washed microbiota preparation reduced adverse event without discounting efficacy.
Abstract
Fecal microbiota transplantation (FMT), as an emerging therapy, can be used to treat microbiota related diseases. Progresses in donor screening, washed microbiota preparation, microbiota delivery routes, clinical administrative strategies, and long-term safety are moving FMT forward. Increasing clinical studies, especially those randomized controlled trials about ulcerative colitis and pilot real-word studies about serious inflammatory bowel disease (IBD), have been conducted. This review presents the latest findings about the efficacy, safety and methodology of FMT in treating IBD.
You can search the page for "herpes". It's in Section 5, Short-term and long-term safety of FMT in IBD.
NSAE = Non-serious adverse events.
- Format correct?
- Yes
Last edited: